Medical News Summary: Asthma diagnosis by using Aridol awaiting approval in Australia

About: Asthma diagnosis by using Aridol awaiting approval in Australia
Date: 18 January 2005
Source: PharmaLive
Medical News Summary (summary of medical news story as reported by PharmaLive): Pharmixis Ltd is seeking approval from the Therapeutic Goods Administration to sell its drug Aridol in Australia. Aridol is aimed at diagnosing asthma patients and managing the condition. It is a dry powder which requires an inhaler to deliver it to the lungs. The results can show how severe the asthma is and how beneficial the medication being used is. It can also be used to determine if inhaled steroids will benefit chronic obstructive pulmonary disease sufferers. Aridol treatment can be done in a GP’s office. Clinical trials involving the drug showed a good correlation between a physician’s diagnosis and diagnosis through Aridol. Aridol also suggested that 25% of asthmatics tested needed some change to her medication with about 17% being able to reduce their level of medication without harm.
URL: http://www.pharmalive.com/News/index.cfm?articleid=204995&categoryid=51
Related Disease Topics: Asthma, Chronic obstructive pulmonary disease, COPD

---

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

• Medication
• medication and asthma
• medication and chronic obstructive pulmonary disease
• medication and COPD
• Research
• research and asthma
• research and chronic obstructive pulmonary disease
• research and COPD
• Diagnosis
• Diagnosis and asthma
• Diagnosis and chronic obstructive pulmonary disease
• Diagnosis and COPD

Medical Tools & Articles:

Next articles:

• Risk Factor Center
• Medical Statistics Center
• Medical Treatment Center
• Prevention Center
• Medical Tests Center

Medical Articles:

• Disease & Treatments Search
• Online Diagnosis
• Misdiagnosis Center
• Full list of interesting articles